Michel G Maillard

Title: Michel G Maillard: Innovator in Pharmaceutical Chemistry

Introduction

Michel G Maillard is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents, his work has the potential to impact various medical conditions.

Latest Patents

One of his latest patents focuses on S-substituted 1,3,7-trialkyl-xanthine derivatives. This invention provides 8-substituted 1,3,7-trialkylxanthines that are useful as A.sub.2-selective adenosine receptor antagonists. The compounds include various substituents that enhance their biological activity. Another significant patent involves biologically active ATP analogs, which are designed for the treatment of septic shock and other disease conditions. These ATP analogs include mono-, di-, and triphosphates of adenosines with various selected substituents, showcasing the versatility of his research.

Career Highlights

Michel G Maillard works for the United States of America as represented by the Department of Health. His role in this esteemed organization allows him to contribute to important health-related innovations. His research has led to advancements in pharmaceutical compositions and methods that can be utilized in clinical settings.

Collaborations

Throughout his career, Michel has collaborated with notable colleagues such as Kenneth Alan Jacobson and Bilha Fischer. These partnerships have likely enriched his research and expanded the scope of his inventions.

Conclusion

Michel G Maillard is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to improving health outcomes through scientific research and development.